Translate Bio Inc. (TBIO) is priced at $14.78 after the most recent trading session. At the very opening of the session, the stock price was $14.913 and reached a high price of $15.08, prior to closing the session it reached the value of $14.75. The stock touched a low price of $14.01.
Translate Bio Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $28.09 on 06/24/20, with the lowest value was $6.80 for the same time period, recorded on 03/09/20.
Get Ready for my next COVID-19 stock idea. I have been very fortunate in discovering biotech, therapeutic and diagnostic companies within the COVID-19 space, before wall street catches on. Our goal for our members is to get our Alert’s first before the crowd.
Translate Bio Inc. (TBIO) full year performance was 46.34%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Translate Bio Inc. shares are logging -47.38% during the 52-week period from high price, and 117.35% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $6.80 and $28.09.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 6525204 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Translate Bio Inc. (TBIO) recorded performance in the market was 81.57%, having the revenues showcasing -3.40% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.10B, as it employees total of 93 workers.
Specialists analysis on Translate Bio Inc. (TBIO)
During the last month, 7 analysts gave the Translate Bio Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 16.30, with a change in the price was noted +0.38. In a similar fashion, Translate Bio Inc. posted a movement of +2.64% for the period of last 100 days, recording 1,618,110 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for TBIO is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Trends and Technical analysis: Translate Bio Inc. (TBIO)
Raw Stochastic average of Translate Bio Inc. in the period of last 50 days is set at 32.86%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 68.41%. In the last 20 days, the company’s Stochastic %K was 64.10% and its Stochastic %D was recorded 55.97%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 81.57%. Additionally, trading for the stock in the period of the last six months notably improved by 51.28%, alongside a boost of 46.34% for the period of the last 12 months. The shares increased approximately by 13.78% in the 7-day charts and went up by -2.57% in the period of the last 30 days. Common stock shares were lifted by -3.40% during last recorded quarter.